Biofrontera Inc.
BFRI· Nasdaq
Quarterly figures for Biofrontera Inc., with source filings when available.
24 quarters. Sep 30, 2020 to Jun 30, 2026. USD.
Biofrontera Inc. has filed its 10-Q within 43 to 45 days of period end across its last 8 quarters. The 10-K runs 72 to 101 days.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 13, 2026 · pre-market | Aug 13, 2026 | 44 d | 10-Q | $12.00M | +32.9% | -$0.05 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 14, 2026 · pre-market |
| May 14, 2026 |
| 44 d |
| 10-Q |
| $10.08M |
| +17.4% |
| -$0.41 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 19, 2026 · market hours | Mar 19, 2026 | 78 d | 10-K | $17.10M | +36.2% | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 12, 2025 | 43 d | 10-Q | $6.99M | −22.5% | -$0.62 | |
| Q2 2025 | Jun 30, 2025 | Aug 13, 2025 · after-hours | Aug 13, 2025 | 44 d | 10-Q | $9.03M | +15.2% | -$0.57 | |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 · after-hours | May 15, 2025 | 45 d | 10-Q | $8.59M | +8.5% | -$0.47 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | Mar 20, 2025 | 79 d | 10-K | $12.56M | +18.5% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · after-hours | Nov 14, 2024 | 45 d | 10-Q | $9.01M | +1.3% | -$0.98 | |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 · after-hours | Aug 14, 2024 | 45 d | 10-Q | $7.84M | +34.0% | -$0.05 | |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 · after-hours | May 15, 2024 | 45 d | 10-Q | $7.91M | −9.4% | -$2.88 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Jan 11, 2024 · after-hours | Mar 15, 2024 | 75 d | 10-K | $10.59M | +4.4% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 · after-hours | Nov 9, 2023 | 40 d | 10-Q | $8.90M | +105.8% | -$4.64 | |
| Q2 2023 | Jun 30, 2023 | Aug 11, 2023 · pre-market | Aug 11, 2023 | 42 d | 10-Q | $5.85M | +31.2% | -$7.23 | |
| Q1 2023 | Mar 31, 2023 | May 12, 2023 · pre-market | May 12, 2023 | 42 d | 10-Q | $8.73M | −10.4% | -$5.60 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Jan 9, 2023 · pre-market | Mar 13, 2023 | 72 d | 10-K | $10.14M | +10.7% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 · pre-market | Nov 14, 2022 | 45 d | 10-Q | $4.32M | −0.3% | -$2.26 | |
| Q2 2022 | Jun 30, 2022 | Aug 12, 2022 · pre-market | Aug 12, 2022 | 43 d | 10-Q | $4.46M | −23.9% | -$0.90 | |
| Q1 2022 | Mar 31, 2022 | May 13, 2022 · pre-market | May 13, 2022 | 43 d | 10-Q | $9.75M | +105.5% | $0.32 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Jan 13, 2022 · pre-market | Apr 11, 2022 | 101 d | 10-K | $9.17M | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 30, 2021 · market hours | Nov 30, 2021 | 61 d | 10-Q | $4.33M | +33.3% | -$2.00 | |
| Q2 2021 | Jun 30, 2021 | — | — | — | — | $5.86M | — | -$0.46 | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | $4.74M | — | -$0.44 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $3.25M | — | -$2,984.67 | |